A research team has identified a drug target for ATRA, a treatment for acute promyelocytic leukemia (APL), by targeting the Pin1 enzyme. The discovery offers a promising new way to fight aggressive or drug-resistant cancers by degrading cancer stem cells and blocking multiple cancer-driving pathways.
The study of genomics effects on placebos introduces the concept of 'the placebome,' identifying a network of genes that significantly influence medicine and clinical trial design. Genetic variations in neurotransmitter pathways modify placebo effects, suggesting placebos play a larger role in healthcare than previously recognized.
A new study found that combining traditional assessment tools with data from nurses' assessments significantly improves the ability to predict survival in cirrhosis patients. This may help improve patient outcomes by identifying patients who can benefit from rehabilitation and intensifying their nutritional support.
Researchers at Beth Israel Deaconess Medical Center found that the non-coding BRAF pseudogene contributes to the development of an aggressive lymphoma-like cancer in animal models. The study suggests that pseudogenes may play a primary role in various diseases and could significantly expand the functional genome.
A new commentary suggests that mandatory screening for women with dense breast tissue without careful analysis of benefits and risks is unwise. Education on the increased risk and other important factors can help healthcare providers guide recommendations for supplemental screening.
A comprehensive review of literature reveals a strong relationship between higher testosterone levels and reduced cardiovascular disease and risk factors. Despite four flawed studies sparking concerns, dozens of studies demonstrate benefits of testosterone therapy in reducing mortality, improving cardiovascular health, and alleviating ...
OurNotes aims to enhance communication and engage patients in managing illness more effectively and efficiently, leading to improved patient safety and quality of care. The project will explore the potential for patients to contribute to their own medical records, building on BIDMC's well-established work in patient engagement.
Researchers found that vaccines eliciting only CD4 T cell responses led to an overwhelming inflammatory reaction in mice, while those with both CD4 and CD8 responses were protected. This study cautions against developing vaccines that solely target one arm of the immune system.
A new BIDMC study suggests that physicians are increasingly ordering advanced imaging and referring specialists for routine headaches, rather than counseling patients on lifestyle changes. This trend has significant consequences, including unnecessary patient anxiety and follow-up testing.
Researchers have identified two transcription factors, GR and VDR, that play a crucial role in the development of insulin resistance. Epigenomic modifications, such as changes in DNA structure, can be passed from cell to cell and between generations, and this study provides insights into how these modifications contribute to the condit...
Ramy Arnaout has been awarded a two-year grant to analyze antibody repertoires of over 1,000 Americans to clarify the link between antibodies, cardiovascular disease, and aging. The goal is to determine individual treatment needs for patients with cardiovascular disease.
A novel combination therapy using low-dose chemotherapy with an antiangiogenic treatment, 3TSR, improved survival rates in an animal model of ovarian cancer. The treatment resulted in tumor regression, improved blood flow, and more efficient delivery of chemotherapy drugs with reduced side effects.
Scientists have developed a novel delivery platform that allows for the inhibition of microRNA activity, leading to controlled cancer growth. The breakthrough uses a peptide with low-pH induced transmembrane structure to target tumor cells, providing a promising new model for cancer therapeutics.
A new study reveals that naturally occurring carbon monoxide is essential for the macrophages' surveillance plan, detecting the presence of bacteria and instigating an attack. CO also boosts the immune response to enhance clearance of bacteria and resolution of SIRS.
A new study from Beth Israel Deaconess Medical Center found that men with osteoporosis-related fractures are under-screened for bone density testing and treatment. The research highlights the importance of evaluating and treating older men for osteoporosis, as fracture rates among men are expected to increase dramatically by 2050.
Research at Beth Israel Deaconess Medical Center identified an unexpected link between the transcription factor FOXP2 and metastatic colonization of breast cancer. Silencing FOXP2 enables breast cancer cells to acquire malignant traits, facilitating their survival and proliferation.
A new three-minute diagnostic assessment, 3D-CAM, detects delirium with greater-than-90-percent specificity and sensitivity, particularly in patients with dementia. The test has the potential to significantly improve detection of this common and morbid condition in vulnerable older hospital patients.
A new study led by Beth Israel Deaconess Medical Center found that fructose ingestion increases blood levels of the hormone FGF21, providing a reliable predictor for altered fructose metabolism. This discovery offers an avenue for further investigation into genetic and environmental determinants of metabolic response to fructose.
A new study from BIDMC found that while patients didn't message doctors more over time, the overall number of messages per doctor increased as more patients enrolled in secure patient web portals. Primary care doctors received 85% of email traffic, despite representing only 40% of the system.
Researchers have identified a new class of lipid molecules that enhance insulin sensitivity and blood sugar control, offering a promising direction for preventing and treating type 2 diabetes. The fatty acid hydroxyl fatty acids (FAHFAs) are produced and broken down inside the human body and may serve as an early marker for the risk of...
Dr. Mark Andermann's five-year $1.5 million grant will investigate neural pathways driving hunger and cravings, with the goal of understanding root causes of obesity and food addiction. His novel imaging techniques may lead to breakthroughs in treating these conditions.
The Beth Israel Deaconess Medical Center will conduct proof-of-concept studies in monkeys and launch Phase 1 and Phase 2 clinical trials to test broadly neutralizing monoclonal antibodies. The goal is to suppress or eradicate HIV in humans, providing an alternative to antiretroviral therapies.
Researchers at Beth Israel Deaconess Medical Center identified brain networks that can help guide site selection for brain stimulation therapies. The findings suggest that stimulating sites in the same connected brain network can improve treatment outcomes across multiple neurological and psychiatric disorders.
A pilot observational study found proactive monitoring and dose adjustment of infliximab resulted in fewer disease recurrences and infusion reactions. The authors propose routine monitoring of IFX concentrations and adjusting doses based on levels for patients with IBD.
A combination therapy of two miRNAs, let-7 and miR-34, has been shown to suppress tumor growth in an animal model of non-small-cell lung cancer. The study offers a promising therapeutic avenue for this aggressive malignancy.
A team of neuroscientists and robotics engineers has demonstrated direct brain-to-brain communication in humans, transmitting information via the internet between two human subjects separated by 5,000 miles. The study used advanced precision neuro-technologies to directly transmit a thought from one person to another without them havin...
A study found that elderly individuals with Alzheimer's disease have fewer inhibitory neurons, leading to fragmented sleep. The researchers discovered a correlation between the number of remaining ventrolateral preoptic neurons and sleep fragmentation, highlighting a potential link between aging and sleep disorders.
Scientists have discovered that the HIV viral reservoir is established remarkably early after infection, posing new challenges for its eradication. The study found that the reservoir was seeded in tissues within days of infection, before detectable virus was present in the blood.
A new study suggests that genetic variation in the COMT gene may modify the cardiovascular benefit of aspirin, with val/val women experiencing more cardiovascular events when assigned to aspirin. In contrast, met/met women showed reduced rates of cardiovascular disease when assigned to either aspirin or vitamin E.
A new study by Beth Israel Deaconess Medical Center identifies IRF4 as a key regulator of brown fat's thermogenic process, driving energy expenditure and cold tolerance. The findings provide a crucial clue to understanding how brown fat burns energy and may lead to the development of novel therapies for obesity and diabetes.
A zebrafish model has identified a drug compound that appears to reverse arrhythmogenic cardiomyopathy (ACM), a hereditary disease leading to sudden death in young people. The findings provide a key first step in developing new therapies for this condition, for which there is currently no preventive treatment.
Researchers at Beth Israel Deaconess Medical Center have identified a new B-cell selection process that influences antibody survival independent of antigen-binding regions. This discovery adds a surprising dimension to the understanding of antibody repertoires and may help shape them to better fight disease.
Researchers have made an unexpected discovery about endothelial cell behavior during angiogenesis, revealing a continuum of migratory states regulated by differential cell-cell adhesions. This new mechanism may contribute to disease progression, including cancer, where blood vessel formation is critical for tumor growth.
Using a novel bioinformatics approach, researchers have found that the approved antimicrobial drug pentamidine may help treat advanced kidney cancer. The study identified gene expression patterns that suggest an antimicrobial may be effective against clear cell renal cancer, a common and highly malignant subtype of kidney cancer.
A new study elucidates how BRCA gene loss accelerates chromosome rearrangements, impairing homologous recombination repair. This discovery could help clinicians guide patient treatment for BRCA mutations of uncertain significance.
Researchers discovered that PTEN mutations contribute to tumorigenesis by regulating different aspects of PTEN biology, and targeting Akt's pathway may be an effective treatment strategy for patients with PTEN mutations. The findings suggest that personalized cancer medicine is urgently needed.
A new single-tablet regimen of ledipasvir and sofosbuvir has proven highly effective in treating patients with HCV genotype 1, with cure rates ranging from 94% to 99%. The therapy shows promise for both first-time and previously treated patients, offering a simpler and more tolerable option than current treatments.
Researchers at Beth Israel Deaconess Medical Center have identified a key enzyme responsible for lactate production in cancer cells, which they inhibit to halt tumor growth and even cause regression. The study's findings offer promising results for new treatments targeting cancer metabolism.
Researchers identified a protein, nicotinamide N-methyltransferase (NNMT), that can be altered to increase energy expenditures. Reducing NNMT levels in fat and liver cells dramatically reduces obesity and diabetes development in mice.
A new study from Beth Israel Deaconess Medical Center suggests that upwards of half of high-risk drinkers experience improved behavior post-weight loss surgery. Seven percent of patients who did not show signs of high-risk drinking at baseline later developed the condition, highlighting the need for better screening and monitoring.
Emergency department usage in Massachusetts rose by up to 2.2% after the implementation of a 2006 state law expanding health care access, according to a study published in Annals of Emergency Medicine. The study found that increased insurance coverage reduced financial barriers to care but did not significantly impact access to timely ...
A study identifies a key role for RBP4 in insulin resistance and inflammation of fat tissue, leading to an increased risk of diabetes. Researchers found that elevated RBP4 levels activate immune cells, triggering chronic inflammation and metabolic dysfunction.
A study published in the European Heart Journal reveals a nearly fivefold increased risk for heart attack in the two hours following an angry outburst. The researchers found that patients with cardiovascular events were more likely to have experienced anger immediately prior to the event.
Researchers have developed silk-based screws and plates that can potentially improve bone remodeling following injury and eliminate the need for surgical removal. The devices were tested in laboratory rats and showed promising results, suggesting they could spare patients from complications associated with metal implants.
Researchers at Beth Israel Deaconess Medical Center have identified the paraventricular nucleus as a key player in regulating hunger. By mapping neural circuits and manipulating upstream neurons, the team discovered that this brain region communicates with AgRP neurons to drive intense motivation for food.
A new study reveals that high levels of glucose in diabetes patients induce the production of PGC-1alpha in endothelial cells, preventing them from growing properly. This leads to vascular dysfunction and impaired wound healing, increasing the risk of microvascular complications.
A genetically engineered mouse model has demonstrated the potent oncogenic role of mutant IDH2 protein in acute myeloid leukemia. The study provides a new tool for evaluating the pharmacological efficacy of potential mutant IDH2 inhibitors and confirms the relevance of this protein as a therapeutic target.
A study by Beth Israel Deaconess Medical Center found that patients' expectations, whether positive, negative, or neutral, significantly influence the effects of both medications and placebos on migraine pain. The researchers discovered that a positive message and powerful medication are essential for effective clinical care.
A study by BIDMC researchers found that African Americans are less likely to consider weight loss surgery due to lower quality of life concerns, not economic barriers. Patients' reported quality of life was a significant motivator for their decision-making process.
A study led by Beth Israel Deaconess Medical Center researchers found that carbon monoxide can prevent tumor growth and amplify chemotherapy's effects, sparing healthy tissue. The findings suggest CO induces an 'anti-Warburg' effect, fueling cancer cell bioenergetics until metabolic exhaustion.